1
LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia
Condition(s): Waldenstrom's Macroglobulinemia Last Updated: September 2, 2012Active, not recruiting
5980 Clinical Trials for: Relapsed, Page 1 of 299
Hide Studies Not Seeking New Volunteers
2
Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
Condition(s): Relapsing-remitting Multiple Sclerosis Last Updated: October 4, 2012Recruiting
3
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Condition(s): Relapsed T-Cell Acute Lymphoblastic Leukemia; Relapsed T-Cell Lymphoblastic Lymphoma Last Updated: March 11, 2013Recruiting
4
Preventing Relapse Following Involuntary Smoking Abstinence
Condition(s): Smoking; Smoking Cessation Last Updated: June 15, 2011Recruiting
5
Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Condition(s): Chronic Lymphocytic Leukemia; CLL Last Updated: September 9, 2010Recruiting
6
Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: March 12, 2013Recruiting
7
Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: March 4, 2011Active, not recruiting
8
Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma
Condition(s): Relapse; Refractory Multiple Myeloma Last Updated: August 3, 2009Completed
9
Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention
Condition(s): Cancer Last Updated: June 25, 2012Recruiting
10
Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
Condition(s): Relapsed and Bortezomib Refractory Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma Last Updated: November 14, 2012Active, not recruiting
11
Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
Condition(s): Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma Last Updated: April 29, 2009Active, not recruiting
12
Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant
Condition(s): Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Chronic Phase Chronic Myelogenous Leukemia; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia Last Updated: March 20, 2013Recruiting
13
Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: May 15, 2008Completed
14
A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
Condition(s): Relapsed Multiple Myeloma; Plateau Phase Multiple Myeloma Last Updated: February 25, 2009Completed
15
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
Condition(s): Substance Use Disorders Last Updated: June 13, 2011Active, not recruiting
16
A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
Condition(s): Chronic Lymphocytic Leukemia Last Updated: May 2, 2011Active, not recruiting
17
Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: December 5, 2012Recruiting
18
Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma
Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Carcinoma Last Updated: December 11, 2012Active, not recruiting
19
Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma
Condition(s): Relapsed Lymphoblastic Leukemia; Relapsed Lymphoblastic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Lymphoblastic Lymphoma Last Updated: November 15, 2012Recruiting
20
Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia
Condition(s): Relapsed/Refractory Leukemia Last Updated: November 23, 2009Terminated
